Damien Thévenin, Ph.D.
Affiliations: | 2011- | Chemistry | Lehigh University, Bethlehem, PA, United States |
Area:
Membrane protein biophysicsWebsite:
http://www.lehigh.edu/~dat311/index.htmlGoogle:
"Damien Thévenin"Bio:
Mean distance: 9.01 | S | N | B | C | P |
Parents
Sign in to add mentor| Brian James Bahnson | grad student | 2007 | University of Delaware | |
| (Roles of transmembrane domains in the folding and assembly of the adenosine A2A receptor.) | ||||
| Donald M. Engelman | post-doc | 2006-2011 | Yale | |
Children
Sign in to add trainee| Elizabeth Bloch | grad student | Lehigh University | |
| Kelly King | grad student | Lehigh University | |
| Janessa Wehr | grad student | 2019 | Lehigh University |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Ankrom ET, Dalesandro B, Pires MM, et al. (2024) Selective Recruitment of Antibodies to Cancer Cells and Immune Cell-mediated Killing via In Situ Click Chemistry. Chemmedchem. e202400356 |
| Kelly JJ, Ankrom ET, Newkirk SE, et al. (2024) Targeted acidosis mediated delivery of antigenic MHC-binding peptides. Frontiers in Immunology. 15: 1337973 |
| Rizzo S, Thévenin D. (2023) Identifying Transmembrane Interactions in Receptor Protein Tyrosine Phosphatase Homodimerization and Heterodimerization. Methods in Molecular Biology (Clifton, N.J.). 2743: 195-209 |
| Kelly JJ, Ankrom E, Thévenin D, et al. (2023) Targeted Acidosis Mediated Delivery of Antigenic MHC-Binding Peptides. Biorxiv : the Preprint Server For Biology |
| Rizzo S, Sikorski E, Park S, et al. (2023) Promoting the Activity of a Receptor Tyrosine Phosphatase with a Novel pH-responsive Transmembrane Agonist Inhibits Cancer-Associated Phenotypes. Protein Science : a Publication of the Protein Society. e4742 |
| Schwarz M, Rizzo S, Paz WE, et al. (2022) Disrupting PTPRJ transmembrane-mediated oligomerization counteracts oncogenic receptor tyrosine kinase FLT3 ITD. Frontiers in Oncology. 12: 1017947 |
| Bloch E, Sikorski EL, Pontoriero D, et al. (2022) Correction: Disrupting the transmembrane domain-mediated oligomerization of protein tyrosine phosphatase receptor J inhibits EGFR-driven cancer cell phenotypes. The Journal of Biological Chemistry. 298: 102416 |
| Vasquez-Montes V, Tyagi V, Sikorski E, et al. (2022) Ca -dependent interactions between lipids and the tumor-targeting peptide pHLIP. Protein Science : a Publication of the Protein Society. 31: e4385 |
| Rizzo S, Sikorski E, Hart W, et al. (2022) Development of Tumor-selective Transmembrane Peptides to Promote the Activity of the Receptor Protein Tyrosine Phosphatase J by Disrupting its Homodimerization. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology |
| Sikorski EL, Wehr J, Ferraro NJ, et al. (2022) Selective Display of a Chemoattractant Agonist on Cancer Cells Activates the Formyl Peptide Receptor 1 on Immune Cells. Chembiochem : a European Journal of Chemical Biology |